新生儿类固醇代谢中的正常化策略:对概率率和同行群体方法的比较分析
Miłosz Lorek1,2, Teresa Joanna Stradomska3, Anna Siejka3
1Department of Neonatal and Pediatric Intensive Care, John Paul II Center for Child and Family Health, Sosnowiec, Poland. lorek.milosz@gmail.com.
同龄人群正常化 (PGN) 有效地减少了新生儿类固醇代谢的变异性,超过了概率系数正常化 (PQN). 这一策略提高了婴儿类固醇分析的数据准确性.
科学领域:
- 新生儿代谢产物新生儿代谢产物
- 对于类固醇的分析
- 生物标志物的分析分析.
背景情况:
- 新生儿类固醇代谢因生理异质性和技术变异性而面临挑战.
- 准确解释代谢物概况需要有效的正常化策略.
研究的目的:
- 为了比较新生儿尿路类固醇特征的同行组规范化 (PGN) 和概率系数规范化 (PQN).
- 评估正常化技术在减少生理变异性和改善数据可比性的有效性.
主要方法:
- 在50名新生儿中分析了24小时的尿路类固醇特征,使用气色谱-质谱.
- PQN和PGN规范化技术的比较.
- 使用分布指标,与人体测量变量相关性以及主要组件分析 (PCA) 评估规范化性能.
主要成果:
- PGN表现出优异的分布正常化,比PQN更多的代谢物符合正常性假设.
- PGN有效地消除了类固醇水平和人类参数之间的相关性,减少了生理上的混.
- 与PQN相比,PCA证实PGN的样本分散和组分离得到了改善.
结论:
- 同龄人群正常化 (PGN) 是一种强有力的策略,用于标准化新生儿类固醇代谢.
- PGN有效地减少了生理变异性,提高了代谢物概况解释的准确性.
- 建议进行进一步的验证,以证明PGN在新生儿学中的实用性.
更多相关视频
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
11:25Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
相关概念视频
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Regression Toward the Mean
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Mechanistic Models: Compartment Models in Individual and Population Analysis
